Recent articles
Here's Why Alder Biopharmaceuticals Is Rocketing Higher Today
A generous buyout offer has given investors something to cheer about.
Cannabis and Big Pharma Join Hands in Jerusalem
The world's largest manufacturer of prescription drugs has officially entered the medical marijuana industry.
3 Biotech Stocks That Soared Last Week
How much longer can they keep it up?
4 Signs of Life in Aurora Cannabis' Latest Earnings Report
Despite missing revenue expectations, Aurora Cannabis laid out some encouraging numbers you may have missed.
Here's Why Moderna Stock Got a Lift Today
The company's long R&D Day presentation gave investors reasons for optimism.
Did the FDA Just Signal Smooth Sailing Ahead For Aimmune Therapeutics?
Here's what a benign briefing document means, and what it doesn't.
Here's Why Aimmune Therapeutics Stock Is Surging Today
The company's peanut allergen desensitization therapy took an indirect step forward.
Is Acadia Pharmaceuticals a Good Biotech Stock to Buy Now?
Lackluster sales of Nuplazid could finally take flight next year.
3 Biotech Stocks That Could Soar This Week
Investors better get ready for a busy week ahead.
2 Biotech Stocks That Could Double Your Money
Hardly anyone's heard of either of these drugmakers, but some analysts think they could be top performers.
4 Biotech Stocks With Big Catalysts in September
Two presentations at the World Conference on Lung Cancer will make a big difference for at least four different drugmakers.
Is Curaleaf a Good Cannabis Stock to Buy Now?
The company has some bold predictions for the year ahead that could make investors very rich.
Here's Why The Medicines Company Stock Soared Again on Tuesday
A detailed look at a big clinical trial did not disappoint.
Is the U.S. Getting on Board With Cannabis Legalization?
Here's what to expect from a government agency that's listening to what people have to say about marijuana legalization.
Here's Why Guardant Health Shares Are Sliding Today
Investors worried about a couple of insider trades put pressure on the stock price.
3 New Biotech Stocks That Keep On Soaring
Can their share prices continue to climb?
Should Amgen Finally Buy Alexion Pharmaceuticals?
One of biotech's longest-running buyout rumors is picking up steam again.
Is Sarepta Therapeutics a Bad News Buy?
Here's what bargain biotech shoppers need to know about Sarepta's future.
Here's Why AnaptysBio Shares Are Slipping Today
An executive's departure at a sensitive time has investors nervous.
Better CBD Stock: Charlotte's Web vs. CV Sciences
Which purveyor of high-margin, nonintoxicating cannabis products will earn the largest share of this growing market?